Company Filing History:
Years Active: 2017-2019
Title: Profiles of Innovation: Inventor Ying Xie from Macau
Introduction
Ying Xie is a distinguished inventor based in Macau, China, whose innovative contributions to the field of biopharmaceuticals have resulted in three patents. His work primarily focuses on improving drug efficacy and treatment methods for chronic diseases, demonstrating a commitment to enhancing the quality of healthcare options.
Latest Patents
Ying Xie's latest patents include a method of increasing the bioavailability of silybin. One specific embodiment outlines a process that involves providing silybin alongside a flavonoid, such as tangeretin or baicalein, to enhance its absorption in the body. Additionally, he has developed a method aimed at treating chronic liver disease, where silybin and a flavonoid are administered to target the illness effectively.
Another significant patent is centered on the use of tangeretin in cancer treatment. This invention presents a pharmaceutical composition designed to combat multidrug-resistant cancers by combining a citrus methoxyflavone, tangeretin, with a chemotherapeutic drug. This innovative approach also includes a method for administering the citrus methoxyflavone alongside the chemotherapeutic treatment.
Career Highlights
Ying Xie's career is closely tied to the Macau University of Science and Technology, where he contributes significantly to research efforts in pharmaceuticals. His work has garnered attention for its potential impact on public health, especially in the realms of liver disease and cancer treatment.
Collaborations
Throughout his career, Ying has had the opportunity to collaborate with notable colleagues, including Liang Liu and Wen-zhe Ma. These partnerships have fostered an environment of innovation and have allowed for the sharing of expertise that enhances the quality of their research.
Conclusion
Ying Xie stands out as a significant figure in the realm of healthcare innovation. His inventive contributions are paving the way for advancements in the treatment of chronic diseases and cancer, highlighting the importance of collaborative research in achieving breakthroughs that can drastically improve patient outcomes.